Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Scholar Rock Holding CorporationNASDAQ: SRRK
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -$102.35M, compared with -$100.46M a year earlier. Trailing-twelve-month EBITDA was -$398.31M.
Context
- EBITDA grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 11 analysts of -$373.12M (-1.0%) for the fiscal year ending Dec 2026, a step up from the -55.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$102.35M+2.6% QoQ
- Last fiscal yearDec 2025
- -$369.39M-55.5% YoY
- LTMSep 2026
- -$398.31M-14.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.9% | +34.4% | +36.3 pp |
| 1 year | -55.5% | -1.0% | +54.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (369.39M) USD
- Year-over-year change
- -55.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (369.39M) | -55.5% |
| FY2024 | 2024-12-31 | (237.52M) | -45.8% |
| FY2023 | 2023-12-31 | (162.95M) | -25.8% |
| FY2022 | 2022-12-31 | (129.48M) | -0.2% |
| FY2021 | 2021-12-31 | (129.17M) | — |
EBITDA vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 EBITDA of -$398.31M is the 7th highest of the 11 companies compared; the peer median is -$182.52M.
- Its year-over-year change of -14.0% is the 4th highest of 11, against a peer median of -30.3%.
- EBITDA amounts to 69878.4% of revenue for SRRK, versus a peer median of 49.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $173.52M | -79.4% | — | 17.2% | |
| LTM Mar 2026 | $124.95M | +217.3% | — | 5.7% | |
| LTM Jun 2026 | -$63.18M | +83.2% | — | 40.5% | |
| LTM Mar 2026 | -$119.51M | -312.9% | — | 597.6% | |
| LTM Mar 2026 | -$164.11M | -405.9% | — | 511.5% | |
| LTM Sep 2026 | -$200.94M | -29.7% | — | — | |
| LTM Sep 2026 | -$398.31M | -14.0% | — | 69878.4% | |
| LTM Sep 2026 | -$434.65M | -30.9% | — | — | |
| LTM Sep 2026 | -$473.54M | -208.3% | — | 49.3% | |
| LTM Jun 2026 | -$495.35M | -20.6% | — | — | |
| LTM Jun 2026 | -$611.26M | +5.0% | — | 85.7% | |
| Peer median (excluding SRRK) | -$182.52M | -30.3% | — | 49.3% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.82M | 33.19M | 0 | 0 | 0 |
| Cost of Revenue | 108.47M | 123.04M | 2.84M | 1.94M | 208.44M |
| Gross Profit | (89.65M) | (89.85M) | (2.84M) | (1.94M) | (208.44M) |
| Gross Margin | -476.5% | -270.7% | — | — | — |
| Research & Development | 108.47M | 124.44M | 119.06M | 182.61M | 208.44M |
| Selling, General & Admin | 40.27M | 42.62M | 49.4M | 67.5M | 176.21M |
| Operating Expenses | 40.27M | 44.52M | 168.45M | 250.12M | 176.21M |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| EBITDA | (129.17M) | (129.48M) | (162.95M) | (237.52M) | (369.39M) |
| EBITDA Margin | -686.5% | -390.1% | — | — | — |
| Operating Income | (129.92M) | (134.37M) | (171.3M) | (252.05M) | (384.65M) |
| Operating Margin | -690.5% | -404.8% | — | — | — |
| Interest Income | 0 | 0 | 0 | 12.68M | 13.9M |
| Interest Expense | 0 | 0 | 0 | 6.84M | 6.89M |
| Other Income / Expenses | (1.88M) | (132K) | 5.51M | 5.76M | 6.71M |
| Income Before Tax | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Pre-Tax Margin | -700.5% | -405.2% | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Net Margin | -700.5% | -405.2% | — | — | — |
| EPS (Basic) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| EPS (Diluted) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| Weighted Avg Shares | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
| Weighted Avg Shares (Diluted) | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.